CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464900. A total of 4 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $456,000 | -95.0% | 67 | -94.0% | 0.04% | -93.0% |
| Q3 2017 | $9,163,000 | -65.5% | 1,112 | -60.8% | 0.60% | -65.6% |
| Q2 2017 | $26,582,000 | +28.4% | 2,839 | -12.7% | 1.74% | +55.7% |
| Q1 2017 | $20,705,000 | +38.0% | 3,252 | -3.7% | 1.12% | +27.9% |
| Q4 2016 | $15,005,000 | -28.8% | 3,378 | -42.3% | 0.87% | +10.5% |
| Q3 2016 | $21,089,000 | +845.3% | 5,850 | +259.8% | 0.79% | +581.0% |
| Q2 2016 | $2,231,000 | -37.6% | 1,626 | -12.7% | 0.12% | -35.2% |
| Q1 2016 | $3,575,000 | +308.6% | 1,862 | +644.8% | 0.18% | +272.9% |
| Q4 2015 | $875,000 | -89.4% | 250 | -87.5% | 0.05% | -86.5% |
| Q2 2014 | $8,274,000 | -38.1% | 1,998 | +3.5% | 0.36% | -52.7% |
| Q1 2014 | $13,376,000 | +6424.9% | 1,931 | +5579.4% | 0.75% | +5669.2% |
| Q4 2013 | $205,000 | – | 34 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|